Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2015 | 07-2015 | 04-2015 | 01-2015 | 10-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,461 | -2,913 | -13,140 | -9,463 | -6,684 |
| Depreciation Amortization | 76 | 37 | 214 | 166 | 110 |
| Accounts receivable | -865 | -398 | 265 | 233 | 210 |
| Accounts payable and accrued liabilities | -76 | 22 | 433 | 381 | 651 |
| Other Working Capital | -1,299 | -442 | 524 | 792 | 481 |
| Other Operating Activity | 2,498 | 1,151 | 2,074 | 269 | -15 |
| Operating Cash Flow | $-5,127 | $-2,543 | $-9,630 | $-7,622 | $-5,247 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44 | -29 | -114 | -84 | -71 |
| Investing Cash Flow | $-44 | $-29 | $-114 | $-84 | $-71 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,000 | 2,000 | N/A |
| Debt Repayment | -11 | -7 | -12 | -5 | 0 |
| Common Stock Issued | N/A | N/A | 11,222 | 2 | 2 |
| Other Financing Activity | -18 | -18 | 0 | 0 | 0 |
| Financing Cash Flow | $-29 | $-25 | $13,210 | $1,997 | $2 |
| Beginning Cash Position | 9,357 | 9,357 | 5,891 | 5,891 | 5,891 |
| End Cash Position | 4,157 | 6,760 | 9,357 | 182 | 575 |
| Net Cash Flow | $-5,200 | $-2,597 | $3,466 | $-5,709 | $-5,316 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,127 | -2,543 | -9,630 | -7,622 | -5,247 |
| Capital Expenditure | -44 | -29 | -119 | -84 | -71 |
| Free Cash Flow | -5,171 | -2,572 | -9,749 | -7,706 | -5,318 |